Category: Press Release

  • Canadian Drug Policy Coalition launches national dialogue series on the overdose crisis and COVID-19

    Canadian Drug Policy Coalition launches national dialogue series on the overdose crisis and COVID-19

    canadian drug policy coalition launches dialogues canadian drug policy coalition launches dialogues

    Vancouver, BC—Never before in Canadian history have communities confronted two concurrent public health catastrophes like the overdose crisis, fueled by a toxic drug supply, and a coronavirus pandemic that has uprooted the routines of daily life and society. At the heart of these converging crises are people who use drugs. COVID-19 has made everything worse for this community at a time when overdose deaths are rising across the country and individual health and safety is more precarious than ever.

    In response to this unprecedented time, the Canadian Drug Policy Coalition at Simon Fraser University, in partnership with the Morris J. Wosk Centre for Dialogue, is launching Getting to Tomorrow: Ending the Overdose Crisis—18 public health dialogues across Canada over the next two years aimed at identifying and moving towards solutions to the overdose crisis, in the context of COVID-19, by building consensus and shared meaning.

    “The COVID-19 pandemic has exposed the illegal drug toxicity death crisis as a catastrophic failure of Canada’s current approach to drugs. Governments have moved mountains in response to the COVID-19 pandemic while a coherent pan-Canadian approach to over 16,000 overdose deaths in the past five years has failed to materialize,” said Donald MacPherson, executive director of the Canadian Drug Policy Coalition.

    “We hope the Getting to Tomorrow dialogue series will inform, engage, and inspire Canadians to become more involved in building a new approach to drugs based on principles of public health and human rights, and lead to improved health and safety for all in our communities.”

    ~Donald MacPherson, Canadian Drug Policy Coalition

    Getting to Tomorrow is also hoping to use learnings from the COVID-19 pandemic to improve Canada’s overdose response at a time when lives are being lost at an unprecedented rate. More specifically, Getting to Tomorrow has three main goals:

    • Accelerate the adoption of public health- and human rights-based drug policies to guide government responses to drugs in Canada
    • Empower decision makers and the public to take evidence-based actions by providing the latest research on policies that could end the overdose crisis
    • Engage the public in dialogue on issues related to substance use and drug policy

    The dialogues will happen virtually (open to invited attendees only) and will invite leaders from diverse communities, including people who use drugs, community and business leaders, government officials, First Nations, public health officials, and law enforcement, to share their stories of navigating the challenges of the overdose crisis during a time of pandemic and global instability. By sharing perspectives and stories, communities can come to recognize the commonalities that unite us rather than the differences that set us apart. This can lay the groundwork for transformative change.

    Getting to Tomorrow will begin in Montreal on October 7 with community partner l’Association des intervenants en dépendance du Québec (AIDQ).

    “As Montreal is one of the epicentres of COVID-19 in Canada, the lives of people who use substances are more than ever at risk as the number of overdoses is dramatically rising,” said Sandhia Vadlamudy, executive director of l’Association des intervenants en dépendance du Québec.

    “Having such a dialogue in Montreal, as well as any other city, will help us understand each other’s perspectives and work together towards better longer-term solutions where everybody wins.”

    ~Sandhia Vadlamudy, Association des intervenants en dépendance du Québec

    Getting to Tomorrow is supported by Health Canada through the Substance Use and Addictions Program.

    www.gettingtotomorrow.ca

    Contact

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]
    604-787-4043

    Download PDF Version of Release

    – 30 –

    About Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 60 organizations and 7,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University’s Faculty of Health Sciences. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion.

    About Morris J. Wosk Centre for Dialogue

    Simon Fraser University’s Morris J. Wosk Centre for Dialogue creates real-world impact for society’s most pressing challenges by using dialogue and engagement to co-create solutions, exchange knowledge, support community-engaged learning, and to build the capacity of others in the knowledge and practice of dialogue. They strive to bring together diverse voices, stories, perspectives and experiences, with a goal to increase understanding about others and ourselves. It is a conversational process intended to help us gain insight into complex problems to which no one person holds the answer.

    About Association des intervenants en dépendance du Québec (AIDQ)

    AIDQ is a non-profit organization that includes stakeholders from all sectors interested in the field of addictions in Quebec, such as the public, private and community sectors, public health and social services, education, universities, research, public safety and the workplace. AIDQ’s mission is to promote and support intervention in the areas of prevention, harm reduction, treatment and the social reintegration of people with addictions and those at risk of becoming addicted, through skills development, information, collaboration, and the sharing of expertise.

  • CDPC applauds passing of resolution at NDP annual convention supporting the decriminalization of drugs and safe supply of opioids

    CDPC applauds passing of resolution at NDP annual convention supporting the decriminalization of drugs and safe supply of opioids

    VANCOUVER, BC—This weekend at the NDP’s annual convention in Victoria members unanimously passed an important resolution calling for the decriminalization of the personal possession of drugs and increased funding and support for the distribution of safe, legal forms of opioids. This is an unprecedented and important statement made by members of the provincial NDP underscoring the dire need to act to save lives across the province.

    “This is good news and shows that the membership of the NDP are very clear about what action needs to take place,” said Donald MacPherson, executive director of the Canadian Drug Policy Coalition. “Our question now is: when will we see action on these issues?”

    “Four people a day continue to die in British Columbia as a result of the toxic drug supply, and we need action now.”

    ~Donald MacPherson, Canadian Drug Policy Coalition

    The resolution increases the pressure on the provincial government to act immediately and implement necessary reforms to save lives, similar to how the previous BC Liberals declared a Public Health Emergency back in 2016, which allowed for the opening of overdose prevention sites across the province.

    The motion was brought forward by at least 10 riding associations and unions calling for life-saving changes to drug laws that currently criminalize substance use and people who use drugs—policies that are contributing to the catastrophic loss of life across British Columbia and Canada more generally.

    This past June, the Canadian Drug Policy Coalition, along with allied organizations, urged the government to amend the Police Act to decriminalize personal possession of drugs. Similar calls have been made by the province’s top medical officials, including Dr. Bonnie Henry who in a lengthy report underscored the urgent need for decriminalization. “The current regulatory regime of prohibition-based drug policy and criminalization does little to address the harms related to substance use, but rather supports an increase in social and health harms, an increase in the potency of illegal drugs, as well as an increase in unsafe drug use, stigma, shame, and discrimination,” she wrote.

    We are encouraged by the stated commitment to shift to a public health- and evidence-backed approach to drug policies by turning away from a punitive criminal justice approach. We hope that the provincial government will listen to the wishes of its membership with regard to this issue, which have been unequivocally expressed this weekend.

    Since 2016, 4375 people across British Columbia have died from opioid-related causes.

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]
    604-787-4043

    Download PDF Version of Advisory

    – 30 –

    About the Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 60 organizations and 7,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University’s Faculty of Health Sciences. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion.

  • Donald MacPherson, Canadian Drug Policy Coalition executive director, awarded honourary doctorate from Adler University

    Donald MacPherson, Canadian Drug Policy Coalition executive director, awarded honourary doctorate from Adler University

    The award is the university’s first-ever honourary doctorate in Canada and recognizes the overdose and drug poisoning crisis as a critical human rights and social justice issue of our time

    VANCOUVER, BC—Donald MacPherson, executive director of the Canadian Drug Policy Coalition and author of the seminal Four Pillars Drug Strategy, today received Adler University’s first-ever honourary doctorate in Canada. The university chose MacPherson for his pioneering work in drug policy reform, advocacy, and advancing the human rights and social inclusion of people who use substances.

    “Donald MacPherson exemplifies the social justice work that we pursue at Adler University,” said Joy MacPhail, Chair of the Board of Trustees at Adler University. “His cutting-edge efforts aim to improve public health and safety by reforming drug policies and by promoting the human rights of people who use substances. His work reminds us how much more needs to be done to address the overdose crisis and we hope our graduates are inspired by MacPherson’s advocacy to advance social justice throughout their careers.”

    The award is also a recognition of the tragic loss of life caused by the illicit, unregulated drug market—a product of our flawed drug policies—as a defining human rights and social justice issue of our time. “I am honoured to receive this award from Adler University and the acknowledgement that the work to change archaic and harmful public policies is one of the challenges of our times,” said MacPherson. “We are living through a time of catastrophic failure of the way we approach people who use criminalized drugs. Our systems are terribly broken and must be replaced.”

    In Canada, 12,813 people have died from opioid-related deaths between 2016 and March 2019. Life expectancy has failed to increase for the first time in over four decades; and in British Columbia, overdose death is now the largest major cause of unnatural death, outpacing accidental deaths from homicides, suicides, and car accidents combined. The provinces of Alberta and Ontario have also been especially hard hit, with Ontario last year recording a record number of fatalities from overdose.

    “We are living through a time of catastrophic failure of the way we approach people who use criminalized drugs. Our systems are terribly broken and must be replaced.”

    ~Donald MacPherson, Canadian Drug Policy Coalition

    MacPherson has been a guest lecturer for Adler University’s public policy and administration program. All Adler University graduate-level degree programs are strongly rooted in the principles of social justice and offer students hands-on learning experiences at more than 200 community partner organizations. Many students work at organizations that address the overdose crisis, providing mental health and other services.

    MacPherson is also an adjunct professor in Simon Fraser University’s Faculty of Health Sciences, of which the Canadian Drug Policy Coalition is a part, and co-author of Raise Shit! Social Action Saving Lives (2009) and More Harm than Good: Drug Policy in Canada (2016). He is involved in drug policy work at a local, national, and international level and was North America’s first Drug Policy Coordinator at the City of Vancouver where he worked for 22 years. Full bio here.

    Contact

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]
    604-787-4043

    Download PDF Version of Advisory

    – 30 –

    About the Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 60 organizations and 7,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University’s Faculty of Health Sciences. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion. www.drugpolicy.ca

    About Adler University

    Adler University is committed to improving individual and community health and well-being through positive social change. At the centre of downtown Vancouver, Adler University is an independent nonprofit institution of higher learning that offers graduate degree programs in psychology, counselling, and public policy. Established in 1952, Adler University has campuses in Vancouver, Chicago, and online. Adler University’s mission is to continue the pioneering work of Alfred Adler, the first community psychologist, by graduating socially responsible practitioners, engaging communities, and advancing social justice. www.adler.edu

  • Donald MacPherson, Canadian Drug Policy Coalition Executive Director, receives Lifetime Achievement Award

    Donald MacPherson, Canadian Drug Policy Coalition Executive Director, receives Lifetime Achievement Award

    Vancouver, BC—The BC Centre on Substance Use (BCCSU) has awarded drug policy advocate, Donald MacPherson, with a Lifetime Achievement Award for his dedication to public health, human rights, and drug policy reform. This honour recognizes a passionate and visionary health advocate who has made substantial contributions to the advancement of evidence-based approaches to substance use and addiction.

    “Donald has consistently put personal comfort aside to move drug policy forward, helping advance harm reduction and human rights for people who use drugs,” says Dr. Lindsey Richardson, who presented Donald with the Lifetime Achievement Award at the BC Substance Use Conference, organized by the BCCSU.

    “Just as important as these accomplishments is how he approaches the people he works with as fulsome, complex humans, with hopes and dreams, and challenges and needs.”

    ~Dr. Lindsey Richardson, BCCSU

    The inaugural award recognizes individuals who have made outstanding contributions in health and health policy, and who have demonstrated an enduring personal commitment to the advancement of health equity. “It is a real honour to receive this award from the BCCSU. It’s quite humbling as there are so many others in British Columbia who have done so much to move us towards a point where we have no choice but to acknowledge our current policies based on criminalization, punishment, and prohibition have been a catastrophic failure,” said Donald MacPherson, Executive Director of the Canadian Drug Policy Coalition.

    “It is time for a true public health and human rights response to drugs in this country.”

    ~Donald MacPherson, Canadian Drug Policy Coalition

    The Lifetime Achievement Award is awarded to national or international leaders who actively participate in health advocacy and activities at a local, provincial, national, and international level.

    Contact

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]
    604-787-4043

    Download PDF Version of Advisory

    – 30 –

    About Donald MacPherson

    Donald MacPherson is the Executive Director of the Canadian Drug Policy Coalition and one of Canada’s leading figures in drug policy. He advocates drug policies based on principles of public health, scientific evidence, human rights, and social inclusion. He is involved in drug policy work at local, national, and international levels, and is a founding member of the Canadian Drug Policy Coalition. Formerly, MacPherson was North America’s first Drug Policy Coordinator at the City of Vancouver where he worked for 22 years. He is the author of Vancouver’s ground-breaking Four Pillars Drug Strategy, which called for new approaches to drug problems based on public health principles and the appropriate regulation of all psychoactive substances. MacPherson is also co-author of Raise Shit! Social Action Saving Lives (2009) and More Harm than Good: Drug Policy in Canada (2016). In 2007, he received the Kaiser Foundation National Award of Excellence in Public Policy in Canada. In 2009, he was awarded the Richard Dennis Drug Peace Award for Outstanding Achievement in the Field of Drug Policy Reform by the Drug Policy Alliance in the United States, and the City of Vancouver was awarded the Canadian Urban Institutes Secure City Award for the Four Pillars Drug Strategy. MacPherson also received the Queen Elizabeth II Diamond Jubilee Medal in 2013 for his work in drug policy reform. In 2017, MacPherson was presented with the Nora and Ted Sterling Prize in Support of Controversy at Simon Fraser University.

    About the BC Substance Use Conference

    The BC Substance Use Conference 2019 is the first annual conference hosted by the BC Centre on Substance Use, bringing together key stakeholders from around the province to discuss provincial efforts to treat and care for people with substance use disorders. This three-day event included research, education, and clinical care guidance presentations and workshops across several topics within substance use, including opioid, alcohol, and cannabis use disorders.

    About the Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 60 organizations and 7,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University’s Faculty of Health Sciences. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion.

  • Public forum to look at models of legal regulation of drugs in Canada

    Public forum to look at models of legal regulation of drugs in Canada

    Going beyond decriminalization and envisioning a post-prohibition Canada where substances are legal and regulated

    What: Community forum featuring an international panel of experts on drug policy and experts with lived experience to debate how Canada can create a system of legal regulation of drugs grounded in social inclusion, human rights, and compassion. What would these systems look like? How would they be implemented? What broader impacts would they have?

    When: Wednesday, May 15, 7:00 p.m. – 9:00 p.m.

    Where: SFU Goldcorp Centre for the Arts, Djavad Mowafaghian Cinema (149 West Hastings St, Vancouver)

    Who: Panel will be moderated by award-winning broadcaster, activist, and member of the Vancouver Area Network of Drug Users, Garth Mullins, and will include the following:

    • Zara Snapp, Co-founder, Instituto RIA (human rights/research organization proposing innovative solutions on drug policies) – Mexico
    • Steve Rolles, Senior Policy Analyst, Transform Drug Policy Foundation (played a role advising Canadian government on its cannabis regulation model) – United Kingdom
    • Akwasi Owusu-Bempah, Professor, Sociology, University of Toronto – Canada
    • Suzanne Fraser, Professor, Public Health, Curtin University – Australia

    From left to right: Garth Mullins, Zara Snapp, Akwasi Owusu-Bempah, Steve Rolles, Suzanne Fraser

    Why: Current drug policies in Canada are a catastrophic failure. These policies have created a toxic drug supply that has killed more than 10,000 Canadians since 2016. Urgent action is needed to stem the tide of fatalities. Decriminalization, which health officials, doctors, and politicians, have openly supported, is a welcome step forward. And it’s imperative that we get at the heart of the crisis: the toxic drug supply.

    Legal regulation of drugs must be explored if we are to end the loss of life. This public forum will bring us one step closer to realizing this vision, relying on the insight of people with lived experience and international experts in the field of drug policy.

    Contact

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]

    Emily Jenkins
    Assistant Professor
    UBC School of Nursing
    [email protected]

    Download PDF Version of Advisory

    – 30 –

    About the Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 70 organizations and 3,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University under the Centre for Applied Research in Mental Health and Addiction. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion.

    Panelist Biographies

    Garth Mullins is a person who uses drugs, an activist, and an award-winning radio documentarian. He is the host and executive producer of the Crackdown Podcast, where drug users cover the drug war as war correspondents. This is Garth’s second overdose crisis. He used injection heroin for over a decade and is now on methadone. He is a member of the Vancouver Area Network of Drug Users and is also a trade union organizer and musician. (Photo credit: Rob Newell)

    Zara Snapp is the co-founder of Instituto RIA, board member of ReverdeSer Colectivo (Mexico), and the international advisor for Acción Técnica Social (Colombia). From 2014-2017, she formed part of the Secretariat of the Global Commission on Drug Policy, where she focused on the Latin American strategy and UNGASS 2016. As a Truman Scholar and Public Service Fellow, she received a Masters in Public Policy from the Kennedy School of Government at Harvard University.

    Steve Rolles is Senior Policy Analyst for the Transform Drug Policy Foundation, a UK-based think tank and charity focused on drug policy and law reform. Steve has served as an adviser for the Global Commission on Drugs and the Uruguayan and Canadian governments in developing their cannabis regulation models. He has worked closely with The LOOP in the UK facilitating the roll-out of drug safety testing at festivals.

    Akwasi Owusu-Bempah, PhD (Toronto), is an assistant professor in the Department of Sociology at the University of Toronto. Dr. Owusu-Bempah’s work focuses on the intersections of race, crime, and criminal justice, with a particular interest in the area of policing. He is currently studying various aspects of cannabis legalization in Canada and the United States. His research has recently been published in Policing and Society, Crime and Justice, and Theoretical Criminology.

    Suzanne Fraser is a professor of public health (Curtin University, Australia). She is program leader for the National Drug Research Institute’s Social Studies of Addiction Concepts Research Program and author of numerous books on the body and health in society and culture. Her most recent, Habits: Remaking Addiction, is co-authored with David Moore and Helen Keane. Suzanne’s main research projects at present are two Australian Research Council-funded studies. One is exploring injecting practices and harm reduction needs among men who inject performance and image-enhancing drugs, and the other is investigating impediments to the uptake and diffusion in Australia of take-home naloxone, the opioid overdose medication known to save lives. This project will be used to create an online resource presenting accounts of overdose revival and take-home naloxone use, which will be linked to the internationally-praised website she built with colleagues on lived experiences of addiction, Livesofsubstance.org.

    (Event Sponsors)
    (Event Organizers)
  • Canadian Drug Policy Coalition and Pivot Legal Society successfully defend supervised consumption at Federal Court of Canada

    Canadian Drug Policy Coalition and Pivot Legal Society successfully defend supervised consumption at Federal Court of Canada

    The precedent-setting decision protects public health and harm reduction efforts from unnecessary barriers and interference from third parties

    Vancouver, BC – This week, the Honourable Justice Mosley released his decision on a judicial review application brought forward by Edmonton’s Chinatown and Area Business Association (CABA). CABA challenged the approval of three desperately-needed supervised consumption sites in downtown Edmonton, asserting that it was not adequately consulted in Health Canada’s decision to approve the services.

    In December 2018, the Canadian Drug Policy Coalition (CDPC), represented by Pivot Legal Society’s Caitlin Shane and Ethos Law Group’s Monique Pongracic-Speier (QC), intervened in the case, arguing that CABA and other third parties do not have a mandatory right to weigh in on the approval of consumption sites in Canada. Instead, public health and safety should be the principal concern of the government in considering applications, as this would best protect the Constitutional rights to safety and security for people who use drugs accessing life-saving services.

    Justice Mosley agreed with our arguments and dismissed CABA’s application, citing directly from our submissions. In his decision, he writes:

    “The process [to approve a supervised consumption site] is both discretionary and non-adjudicative. The principal and mandatory focus of the legislation is on the question of whether [approval] would provide public health benefits. Any consideration of negative impacts on the local community is secondary and discretionary.”

    “This is a precedent-setting decision helping people to save lives amid a national health crisis,” said Donald MacPherson, Executive Director of the Canadian Drug Policy Coalition. “Justice Mosley’s decision means that frontline healthcare providers wishing to offer life-saving supervised consumption services can do so without unnecessary delays. It restores public health as the key concern for approving these sites.”

    The Canadian Drug Policy Coalition and Pivot Legal Society argued that allowing community groups extraordinary consultation privileges would create new barriers to supervised consumption services. The Federal Court of Canada agreed, and the Constitutionally-protected right to health services for people who use drugs rightly took precedence. We are encouraged by the Court’s findings.

    Contact

    Peter Kim
    Strategic Communications Manager
    Canadian Drug Policy Coalition
    [email protected]
    604-787-4043

    Download PDF Version of Media Release

    – 30 –

    About the Canadian Drug Policy Coalition

    The Canadian Drug Policy Coalition (CDPC) is a coalition of 60 organizations and 7,000 individuals working to support the development of progressive drug policy grounded in science, guided by public health principles, and respectful of human rights. The CDPC operates as a project within Simon Fraser University’s Faculty of Health Sciences. The CDPC seeks to include people who use drugs and those harmed by the war on drugs in moving toward a healthier Canadian society free of stigma and social exclusion.